NFKB1 and cancer: Many previous studies illustrated that MTDH can enhance tumor progression and metastasis through activating several classic cancer-promoting signaling pathways, such as epithelial-mesenchymal transition (EMT) [12, 13] and the NF-κB [14–16] and MAPK [17] signaling pathways.